The molecular basis of cancer / John Mendelsohn, MD, Director, Khalifa Institute for Personalized Cancer Therapy and Past President, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; Joe W. Gray, PhD, Gordon Moore Endowed Chair, Chairman, Department of Biomedical Engineering, Director, OHSU Center for Spatial Systems Biomedicine, Associate Director for Translational Research, Knight Cancer Institute, Oregon Health and Science University (OHSU), Portland, Oregon; Peter M. Howley, MD, Shattuck Professor of Pathological Anatomy, Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston, Massachusetts; Mark A. Israel, MD, Director, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, Professor of Pediatrics and Genetics, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire; Craig B. Thompson, MD, President and CEO, Memorial Sloan-Kettering Cancer Center, New York, New York.